Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -20.89% vs -0.59% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -45.90% vs 14.66% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 13.39% vs 1.42% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -24.69% vs 0.34% in Mar 2024
Compare Profit and Loss Results of Beryl Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
21.00
28.00
-7.00
-25.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
21.00
28.00
-7.00
-25.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
11.00
21.00
-10.00
-47.62%
Power & Fuel Cost
1.00
1.00
0.00
0.00%
Employee Cost
2.00
2.00
0.00
0.00%
Operating Expenses
2.00
0.00
2.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
0.00
2.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
27.00
-8.00
-29.63%
Operating Profit (PBDIT) excl Other Income
1.00
0.00
1.00
0%
Other Income
1.00
0.00
1.00
0%
Operating Profit (PBDIT)
2.00
0.00
2.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
2.00
0.00
2.00
0%
Depreciation
1.00
1.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
0.00
-1.00
1.00
100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
-2.00
2.00
100.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
-2.00
2.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3.00
-4.00
7.00
175.00%
Profit Available for appropriations
4.00
-6.00
10.00
166.67%
Appropriations
4.00
-6.00
10.00
166.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.14
-5.6
6.74
120.36%
Profit And Loss - Net Sales
Net Sales 21.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -20.89% vs -0.59% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -45.90% vs 14.66% in Mar 2024
Profit And Loss - Interest
Interest 0.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 13.39% vs 1.42% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 0.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -24.69% vs 0.34% in Mar 2024






